Tatjana Zekić

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 7

Top Topics

Rheumatoid Arthritis

Peritoneal Dialysis

Interstitial Lung Disease

Coronavirus Disease

Top Venues

Rheumatology international

This page only lists publications with an associated author ORCID identifier.

Publications

Tatjana Zekić, Andrej Belančić
Antiphospholipid syndrome, thrombosis, and vaccination in the COVID-19 pandemic. Rheumatology international 44 (5) (2024)
Tatjana Zekić, Andrej Belančić
Antiphospholipid syndrome, thrombosis, and vaccination in the COVID-19 pandemic. Rheumatology international 44 (5) (2024)
Tatjana Zekić, Andrej Belančić
Antiphospholipid syndrome, thrombosis, and vaccination in the COVID-19 pandemic. Rheumatology international (2024)
Tatjana Zekić
Rituximab as the first-line therapy in anti-synthetase syndrome-related interstitial lung disease. Rheumatology international (2023)
Tatjana Zekić, Mirjana Stanić Benić
Anti-programmed death-1 inhibitor nivolumab-induced immune-related adverse events: hepatitis, renal insufficiency, myositis, vitiligo, and hypothyroidism: a case-based review. Rheumatology international (2022)
Tatjana Zekić, Mirjana Stanić Benić, Mislav Radic
Treatment of rheumatoid arthritis with conventional, targeted and biological disease-modifying antirheumatic drugs in the setting of liver injury and non-alcoholic fatty liver disease. Rheumatology international 42 (10) (2022)
Tatjana Zekić
Cardiac involvement in eosinophilic granulomatosis with polyangiitis. Rheumatology international 38 (4) (2017)